Trodelvy and Keytruda combo succeeds in Phase 3 breast cancer study

Gilead's antibody-drug conjugate Trodelvy combined with Merck's Keytruda reduced the risk of disease progression or death in a key study of an aggressive form of breast cancer. Gilead announced Monday that ...

Apr 21, 2025 - 14:26
 0
Trodelvy and Keytruda combo succeeds in Phase 3 breast cancer study
Gilead's antibody-drug conjugate Trodelvy combined with Merck's Keytruda reduced the risk of disease progression or death in a key study of an aggressive form of breast cancer. Gilead announced Monday that ...